A Multicenter Study to Assess the Efficacy of 506U78 in Patients With Chronic Lymphocytic Leukemia Who Are Refractory to Fludarabine and Alkylator Therapy
Latest Information Update: 03 Jul 2023
At a glance
- Drugs Nelarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 May 2014 New trial record